nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—DRD5—attention deficit hyperactivity disorder	0.172	0.212	CbGaD
Pramipexole—ADRA2C—attention deficit hyperactivity disorder	0.162	0.2	CbGaD
Pramipexole—DRD4—attention deficit hyperactivity disorder	0.0879	0.108	CbGaD
Pramipexole—HTR1B—attention deficit hyperactivity disorder	0.078	0.0961	CbGaD
Pramipexole—DRD3—attention deficit hyperactivity disorder	0.0758	0.0933	CbGaD
Pramipexole—DRD1—attention deficit hyperactivity disorder	0.0744	0.0916	CbGaD
Pramipexole—ADRA2A—attention deficit hyperactivity disorder	0.0691	0.0851	CbGaD
Pramipexole—DRD2—attention deficit hyperactivity disorder	0.0524	0.0646	CbGaD
Pramipexole—HTR2A—attention deficit hyperactivity disorder	0.0405	0.0499	CbGaD
Pramipexole—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00338	0.0843	CbGeAlD
Pramipexole—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.0018	0.0448	CbGeAlD
Pramipexole—DRD5—forebrain—attention deficit hyperactivity disorder	0.00141	0.0351	CbGeAlD
Pramipexole—DRD1—forebrain—attention deficit hyperactivity disorder	0.00108	0.0268	CbGeAlD
Pramipexole—DRD4—brain—attention deficit hyperactivity disorder	0.000886	0.0221	CbGeAlD
Pramipexole—HTR1B—forebrain—attention deficit hyperactivity disorder	0.000871	0.0217	CbGeAlD
Pramipexole—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.000851	0.0212	CbGeAlD
Pramipexole—HTR1D—forebrain—attention deficit hyperactivity disorder	0.000844	0.021	CbGeAlD
Pramipexole—HTR2C—forebrain—attention deficit hyperactivity disorder	0.000835	0.0208	CbGeAlD
Pramipexole—DRD3—nervous system—attention deficit hyperactivity disorder	0.000815	0.0203	CbGeAlD
Pramipexole—DRD3—central nervous system—attention deficit hyperactivity disorder	0.000785	0.0196	CbGeAlD
Pramipexole—HTR2B—forebrain—attention deficit hyperactivity disorder	0.000785	0.0195	CbGeAlD
Pramipexole—DRD5—nervous system—attention deficit hyperactivity disorder	0.000764	0.019	CbGeAlD
Pramipexole—HTR1B—cardiovascular system—attention deficit hyperactivity disorder	0.000737	0.0184	CbGeAlD
Pramipexole—DRD5—central nervous system—attention deficit hyperactivity disorder	0.000736	0.0183	CbGeAlD
Pramipexole—HTR1D—cardiovascular system—attention deficit hyperactivity disorder	0.000713	0.0178	CbGeAlD
Pramipexole—DRD1—midbrain—attention deficit hyperactivity disorder	0.00071	0.0177	CbGeAlD
Pramipexole—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000703	0.0175	CbGeAlD
Pramipexole—HTR2B—cardiovascular system—attention deficit hyperactivity disorder	0.000664	0.0165	CbGeAlD
Pramipexole—DRD2—forebrain—attention deficit hyperactivity disorder	0.000635	0.0158	CbGeAlD
Pramipexole—DRD3—brain—attention deficit hyperactivity disorder	0.000623	0.0155	CbGeAlD
Pramipexole—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000595	0.0148	CbGeAlD
Pramipexole—DRD5—brain—attention deficit hyperactivity disorder	0.000584	0.0145	CbGeAlD
Pramipexole—DRD1—nervous system—attention deficit hyperactivity disorder	0.000584	0.0145	CbGeAlD
Pramipexole—HTR1B—midbrain—attention deficit hyperactivity disorder	0.000575	0.0143	CbGeAlD
Pramipexole—DRD1—central nervous system—attention deficit hyperactivity disorder	0.000562	0.014	CbGeAlD
Pramipexole—HTR1D—midbrain—attention deficit hyperactivity disorder	0.000557	0.0139	CbGeAlD
Pramipexole—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000552	0.0137	CbGeAlD
Pramipexole—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000493	0.0123	CbGeAlD
Pramipexole—HTR1B—nervous system—attention deficit hyperactivity disorder	0.000473	0.0118	CbGeAlD
Pramipexole—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000464	0.0116	CbGeAlD
Pramipexole—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.000462	0.0115	CbGeAlD
Pramipexole—HTR1D—nervous system—attention deficit hyperactivity disorder	0.000458	0.0114	CbGeAlD
Pramipexole—HTR1B—central nervous system—attention deficit hyperactivity disorder	0.000455	0.0113	CbGeAlD
Pramipexole—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000453	0.0113	CbGeAlD
Pramipexole—DRD1—brain—attention deficit hyperactivity disorder	0.000446	0.0111	CbGeAlD
Pramipexole—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.000445	0.0111	CbGeAlD
Pramipexole—HTR1D—central nervous system—attention deficit hyperactivity disorder	0.000441	0.011	CbGeAlD
Pramipexole—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000437	0.0109	CbGeAlD
Pramipexole—HTR2B—nervous system—attention deficit hyperactivity disorder	0.000426	0.0106	CbGeAlD
Pramipexole—DRD2—midbrain—attention deficit hyperactivity disorder	0.00042	0.0105	CbGeAlD
Pramipexole—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000419	0.0104	CbGeAlD
Pramipexole—HTR2B—central nervous system—attention deficit hyperactivity disorder	0.00041	0.0102	CbGeAlD
Pramipexole—ADRA2C—midbrain—attention deficit hyperactivity disorder	0.000408	0.0102	CbGeAlD
Pramipexole—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000382	0.00951	CbGeAlD
Pramipexole—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000367	0.00915	CbGeAlD
Pramipexole—HTR1B—brain—attention deficit hyperactivity disorder	0.000362	0.00901	CbGeAlD
Pramipexole—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000359	0.00895	CbGeAlD
Pramipexole—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000354	0.00883	CbGeAlD
Pramipexole—SLC22A1—brain—attention deficit hyperactivity disorder	0.000353	0.0088	CbGeAlD
Pramipexole—HTR1D—brain—attention deficit hyperactivity disorder	0.00035	0.00872	CbGeAlD
Pramipexole—HTR2C—brain—attention deficit hyperactivity disorder	0.000347	0.00863	CbGeAlD
Pramipexole—DRD2—nervous system—attention deficit hyperactivity disorder	0.000345	0.00859	CbGeAlD
Pramipexole—ADRA2C—nervous system—attention deficit hyperactivity disorder	0.000335	0.00835	CbGeAlD
Pramipexole—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000332	0.00827	CbGeAlD
Pramipexole—HTR2B—brain—attention deficit hyperactivity disorder	0.000326	0.00811	CbGeAlD
Pramipexole—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000325	0.00811	CbGeAlD
Pramipexole—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000325	0.00808	CbGeAlD
Pramipexole—ADRA2C—central nervous system—attention deficit hyperactivity disorder	0.000323	0.00804	CbGeAlD
Pramipexole—ADRA2C—cerebellum—attention deficit hyperactivity disorder	0.000316	0.00786	CbGeAlD
Pramipexole—HTR1A—brain—attention deficit hyperactivity disorder	0.000292	0.00727	CbGeAlD
Pramipexole—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000277	0.00689	CbGeAlD
Pramipexole—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000268	0.00666	CbGeAlD
Pramipexole—DRD2—brain—attention deficit hyperactivity disorder	0.000264	0.00657	CbGeAlD
Pramipexole—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000258	0.00642	CbGeAlD
Pramipexole—ADRA2C—brain—attention deficit hyperactivity disorder	0.000256	0.00638	CbGeAlD
Pramipexole—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000252	0.00627	CbGeAlD
Pramipexole—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000227	0.00567	CbGeAlD
Pramipexole—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000219	0.00546	CbGeAlD
Pramipexole—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000214	0.00533	CbGeAlD
Pramipexole—ADRA2A—brain—attention deficit hyperactivity disorder	0.000204	0.00509	CbGeAlD
Pramipexole—HTR2A—brain—attention deficit hyperactivity disorder	0.000174	0.00433	CbGeAlD
Pramipexole—DRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.35e-05	9.09e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.34e-05	9.06e-05	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.34e-05	9.05e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.33e-05	8.98e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.33e-05	8.97e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.33e-05	8.95e-05	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.32e-05	8.94e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.32e-05	8.93e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.32e-05	8.92e-05	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.32e-05	8.91e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.31e-05	8.88e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.31e-05	8.88e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.3e-05	8.8e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.3e-05	8.78e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	1.29e-05	8.74e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.29e-05	8.7e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.29e-05	8.69e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.28e-05	8.67e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.28e-05	8.64e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.28e-05	8.63e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	1.28e-05	8.63e-05	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.28e-05	8.63e-05	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.27e-05	8.61e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.27e-05	8.6e-05	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.27e-05	8.56e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.26e-05	8.51e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.26e-05	8.49e-05	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.26e-05	8.49e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.25e-05	8.45e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.25e-05	8.43e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.24e-05	8.39e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.24e-05	8.39e-05	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	1.24e-05	8.38e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.24e-05	8.38e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.24e-05	8.36e-05	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.24e-05	8.36e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.24e-05	8.35e-05	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.23e-05	8.33e-05	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	1.23e-05	8.31e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.23e-05	8.29e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.22e-05	8.25e-05	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.22e-05	8.22e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.22e-05	8.22e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.22e-05	8.22e-05	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.22e-05	8.21e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.2e-05	8.12e-05	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.2e-05	8.11e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.2e-05	8.1e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.2e-05	8.08e-05	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.2e-05	8.08e-05	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.2e-05	8.08e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.2e-05	8.08e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.19e-05	8.06e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.18e-05	8e-05	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.18e-05	7.98e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.17e-05	7.93e-05	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.17e-05	7.91e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	1.16e-05	7.84e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.16e-05	7.84e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.16e-05	7.83e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.16e-05	7.82e-05	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.15e-05	7.79e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.15e-05	7.77e-05	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.14e-05	7.72e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	1.14e-05	7.72e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.14e-05	7.71e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.13e-05	7.63e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—TPH2—attention deficit hyperactivity disorder	1.13e-05	7.63e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.13e-05	7.6e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.12e-05	7.59e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.12e-05	7.56e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.12e-05	7.54e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.12e-05	7.54e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.11e-05	7.51e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—DPYD—attention deficit hyperactivity disorder	1.11e-05	7.51e-05	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.11e-05	7.48e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.11e-05	7.47e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.1e-05	7.46e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.1e-05	7.44e-05	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.1e-05	7.43e-05	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.1e-05	7.43e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.09e-05	7.37e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.09e-05	7.36e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.09e-05	7.34e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.09e-05	7.34e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.08e-05	7.32e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.08e-05	7.31e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.08e-05	7.31e-05	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.07e-05	7.26e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.07e-05	7.25e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.07e-05	7.21e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.06e-05	7.19e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.06e-05	7.19e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.06e-05	7.17e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.05e-05	7.07e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.05e-05	7.07e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.04e-05	7.01e-05	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.04e-05	7.01e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.03e-05	6.99e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.03e-05	6.98e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.02e-05	6.92e-05	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.02e-05	6.92e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.01e-05	6.84e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.01e-05	6.81e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.01e-05	6.79e-05	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1e-05	6.76e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	9.99e-06	6.75e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.99e-06	6.75e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.96e-06	6.73e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.95e-06	6.72e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.92e-06	6.7e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.9e-06	6.69e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.84e-06	6.64e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.76e-06	6.59e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	9.76e-06	6.59e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.76e-06	6.59e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.75e-06	6.59e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.63e-06	6.51e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.63e-06	6.51e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.62e-06	6.5e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.6e-06	6.49e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.6e-06	6.48e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.55e-06	6.45e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.42e-06	6.37e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.32e-06	6.29e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.3e-06	6.28e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.29e-06	6.28e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.28e-06	6.27e-05	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.24e-06	6.24e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	9.17e-06	6.2e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.17e-06	6.2e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.16e-06	6.19e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.16e-06	6.19e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	9.09e-06	6.14e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.05e-06	6.11e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.03e-06	6.1e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	9.03e-06	6.1e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.97e-06	6.06e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.95e-06	6.05e-05	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.92e-06	6.03e-05	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.88e-06	6e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.84e-06	5.97e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.83e-06	5.96e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.79e-06	5.94e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.69e-06	5.87e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.65e-06	5.85e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.64e-06	5.84e-05	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.63e-06	5.83e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.6e-06	5.81e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.53e-06	5.76e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.52e-06	5.76e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	8.43e-06	5.7e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.43e-06	5.69e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.42e-06	5.69e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.39e-06	5.67e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.39e-06	5.67e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.39e-06	5.67e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.38e-06	5.66e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.35e-06	5.64e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	8.3e-06	5.6e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.24e-06	5.56e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.12e-06	5.49e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.1e-06	5.47e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.08e-06	5.46e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.06e-06	5.45e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.95e-06	5.37e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.84e-06	5.3e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.84e-06	5.3e-05	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.83e-06	5.29e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.83e-06	5.29e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.8e-06	5.27e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.76e-06	5.24e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—EP300—attention deficit hyperactivity disorder	7.75e-06	5.23e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.69e-06	5.2e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.6e-06	5.13e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.56e-06	5.1e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.55e-06	5.1e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.55e-06	5.1e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.52e-06	5.08e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.43e-06	5.02e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.39e-06	4.99e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.37e-06	4.98e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.34e-06	4.96e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.33e-06	4.95e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.31e-06	4.94e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.3e-06	4.93e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.25e-06	4.9e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—EP300—attention deficit hyperactivity disorder	7.24e-06	4.89e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.19e-06	4.86e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.11e-06	4.81e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.1e-06	4.8e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.08e-06	4.78e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	7.04e-06	4.75e-05	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.01e-06	4.74e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	6.99e-06	4.72e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.85e-06	4.63e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—COMT—attention deficit hyperactivity disorder	6.84e-06	4.62e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.83e-06	4.62e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.8e-06	4.59e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—MAOA—attention deficit hyperactivity disorder	6.79e-06	4.59e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.74e-06	4.55e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.63e-06	4.48e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.61e-06	4.47e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.6e-06	4.46e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	6.56e-06	4.43e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.53e-06	4.41e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.52e-06	4.41e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	6.51e-06	4.4e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.44e-06	4.35e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.42e-06	4.33e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.42e-06	4.33e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.37e-06	4.3e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.34e-06	4.28e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.28e-06	4.24e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.18e-06	4.18e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.13e-06	4.14e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.94e-06	4.01e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.9e-06	3.99e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.9e-06	3.99e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	5.88e-06	3.97e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.77e-06	3.9e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.57e-06	3.76e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	5.56e-06	3.75e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	5.52e-06	3.73e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.49e-06	3.71e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.37e-06	3.63e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.96e-06	3.35e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.79e-06	3.23e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.76e-06	3.22e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.63e-06	3.13e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.44e-06	3e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.2e-06	2.84e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.76e-06	2.54e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.4e-06	2.3e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.33e-06	2.25e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.28e-06	2.21e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.13e-06	2.11e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	3.02e-06	2.04e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.95e-06	1.99e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—EP300—attention deficit hyperactivity disorder	2.93e-06	1.98e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.91e-06	1.97e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	2.81e-06	1.9e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.63e-06	1.77e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.54e-06	1.71e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.52e-06	1.7e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.45e-06	1.66e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	2.38e-06	1.61e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.23e-06	1.5e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.19e-06	1.48e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.99e-06	1.35e-05	CbGpPWpGaD
